Operating profit to grow again ahead of Sandoz spin off: Novartis Ruchika Sharma1 Feb 2023 10:00 AM ISTNovartis said in its statement it's on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its...
Sandoz signs agreement to acquire antifungal agent Mycamine from Astellas Ruchika Sharma26 Jan 2023 11:30 AM ISTBasel: Sandoz has signed an agreement to acquire worldwide product rights for systemic antifungal agent Mycamine (micafungin sodium, Funguard in...
Patent infringement: Roche loses US appeal in Sandoz lung disease drug case Ruchika Sharma24 Dec 2022 11:30 AM ISTSan Francisco-based Genentech's Esbriet is used to treat IPF, a serious chronic lung disease. Roche earned over $1 billion last year from worldwide...
CDSCO tells Sandoz to review and report PSUR data of Brolucizumab injection Dr. Divya Colin27 Nov 2022 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has recommended the drug maker...
Sandoz, Teva Pharma plans to ramp up biosimilars production Ruchika Sharma23 Nov 2022 1:30 PM ISTTeva Chief Executive KÃ¥re Schultz said the company was targeting "80% of what's going off-patent in the next 10 years" including big sellers like the...
Former Sandoz Chief Richard Francis joins Teva Pharma as President, CEO Ruchika Sharma22 Nov 2022 1:30 PM ISTPrior to his role at Sandoz, Mr. Francis was a senior executive at Biogen for 13 years where he held a number of senior roles, including leading the...
Novartis considers selling ophthalmology, respiratory units to invest in cutting-edge medicines Ruchika Sharma17 Nov 2022 12:15 PM ISTAny sale of the ophthalmology and respiratory businesses is likely to begin in 2023, after the process for Sandoz is completed, the Bloomberg report...
Novartis to prioritise US market, unfazed by drug pricing pushback Ruchika Sharma25 Sept 2022 2:51 PM ISTNovartis aspire to "organically build its U.S. business to become a top-five player in the U.S. by 2027," it said in a statement.
Novartis plans to shut down Sandoz North Carolina plant by 2023 end Ruchika Sharma12 Sept 2022 12:24 PM ISTZurich: Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on...
Novartis Sandoz division to go independent Ruchika Sharma25 Aug 2022 2:33 PM ISTThe standalone Sandoz would be headquartered in Switzerland and listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in...
Sandoz Supplemental Biologics License application accepted by US FDA for biosimilar Hyrimoz high concentration formulation Ruchika Sharma24 July 2022 10:00 AM ISTAdalimumab is a human immunoglobulin G1 (IgG(1)) monoclonal antibody targeting tumor necrosis factor alpha (TNF-a).
Novartis no longer expects earnings decline at under-review Sandoz unit Ruchika Sharma19 July 2022 12:41 PM ISTNew Delhi: Swiss drugmaker Novartis said earnings at its Sandoz unit, the maker of cheap generic drugs that might be put up for sale, would...
